ID

23752

Descripción

Study part: Adverse Events Week 20. A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Palabras clave

Versiones (1)
  1. 12/7/17 12/7/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

12 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Adverse Events Week 20 Mepolizumab HES NCT00086658

Inglés

Adverse Events Week 20

1 formularios  
  1. StudyEvent: ODM
    1. Adverse Events Week 20
ADVERSE EVENTS
Descripción

ADVERSE EVENTS

Alias
UMLS CUI-1
C0877248
Any new study related non-serious adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events recorded in the appropriate Non-Serious Adverse Events/Serious Adverse Events section?
Descripción

Adverse Events

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0877248
Volver a la parte superior de la página

Similar models

Adverse Events Week 20

1 formularios
  1. StudyEvent: ODM
    1. Adverse Events Week 20
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
ADVERSE EVENTS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Any new study related non-serious adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events recorded in the appropriate Non-Serious Adverse Events/Serious Adverse Events section?
boolean
C0877248 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial